Angiopoietins-1 and -2 play opposing roles in endothelial sprouting of embryoid bodies in 3D culture and their receptor Tie-2 associates with the cell-cell adhesion molecule PECAM1.
暂无分享,去创建一个
[1] S. Gory-Fauré,et al. Role of vascular endothelial-cadherin in vascular morphogenesis. , 1999, Development.
[2] S. Oikawa,et al. Homotypic and heterotypic Ca(++)-independent cell adhesion activities of biliary glycoprotein, a member of carcinoembryonic antigen family, expressed on CHO cell surface. , 1992, Biochemical and biophysical research communications.
[3] Mohammad Tabrizi,et al. A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models , 2010, Molecular Cancer Therapeutics.
[4] E. Dejana,et al. Interendothelial Junctions and their Role in the Control of Angiogenesis, Vascular Permeability and Leukocyte Transmigration , 2001, Thrombosis and Haemostasis.
[5] S. Gray-Owen,et al. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes , 2002, Nature Immunology.
[6] J. Shively,et al. Role of Ceacam1 in VEGF induced vasculogenesis of murine embryonic stem cell-derived embryoid bodies in 3D culture. , 2009, Experimental cell research.
[7] W. Shim,et al. Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis , 2007, Molecular Cancer Research.
[8] Pamela F. Jones,et al. Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning , 1996, Cell.
[9] E. Dejana,et al. The role of JAM‐A and PECAM‐1 in modulating leukocyte infiltration in inflamed and ischemic tissues , 2006, Journal of leukocyte biology.
[10] D. Rimm,et al. PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin. , 1999, Journal of cell science.
[11] P. Kingsley,et al. Initiation of hematopoiesis and vasculogenesis in murine yolk sac explants. , 1995, Blood.
[12] W. Muller. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. , 2003, Trends in immunology.
[13] M. Corada,et al. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148 , 2003, The Journal of cell biology.
[14] M. Mareel,et al. Clinical, cellular, and molecular aspects of cancer invasion. , 2003, Physiological reviews.
[15] F. Orsenigo,et al. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments , 2006, The Journal of cell biology.
[16] J. Shively,et al. The Cell-Cell Adhesion Molecule Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 Inhibits IL-2 Production and Proliferation in Human T Cells by Association with Src Homology Protein-1 and Down-Regulates IL-2 Receptor1 , 2004, The Journal of Immunology.
[17] H. Huland,et al. Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Angiogenesis and Invasion of Human Urinary Bladder Cancer , 2004, Cancer Research.
[18] Y. Kanai,et al. Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis , 2006, Laboratory Investigation.
[19] Yun Li,et al. Direct Interaction of Tumor Suppressor CEACAM1 with Beta Catenin: Identification of Key Residues in the Long Cytoplasmic Domain , 2008, Experimental biology and medicine.
[20] N. Kilic,et al. Pro-angiogenic Signaling by the Endothelial Presence of CEACAM1* , 2005, Journal of Biological Chemistry.
[21] S. Ergün,et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. , 2000, Molecular cell.
[22] S. Albelda,et al. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule , 1991, The Journal of cell biology.
[23] P. Carmeliet,et al. Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis , 1999, Cell.
[24] S. von Kleist,et al. Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation , 1998, European journal of immunology.
[25] B. Imhof,et al. Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. , 1997, The American journal of pathology.
[26] S. Nourshargh,et al. PECAM-1: a multi-functional molecule in inflammation and vascular biology. , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[27] T. Mak,et al. Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. , 1999, Journal of immunology.
[28] Thomas N. Sato,et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.
[29] M. Corada,et al. VE‐cadherin is a critical endothelial regulator of TGF‐β signalling , 2008, The EMBO journal.
[30] S. Ergün,et al. Angiogenic properties of the carcinoembryonic antigen-related cell adhesion molecule 1. , 2000, Experimental cell research.
[31] M. Meissner,et al. Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells. , 2009, Cancer research.
[32] N. Beauchemin,et al. The Carboxyl-terminal Region of Biliary Glycoprotein Controls Its Tyrosine Phosphorylation and Association with Protein-tyrosine Phosphatases SHP-1 and SHP-2 in Epithelial Cells* , 1999, The Journal of Biological Chemistry.
[33] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[34] J. Rossant,et al. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. , 1992, Oncogene.
[35] M. Gertsenstein,et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. , 1994, Genes & development.
[36] C. Mickanin,et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. , 1994, Development.
[37] J. Lilien,et al. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. , 2005, Current opinion in cell biology.
[38] M. Achtman,et al. Carcinoembryonic Antigen Family Receptor Specificity of Neisseria meningitidis Opa Variants Influences Adherence to and Invasion of Proinflammatory Cytokine-Activated Endothelial Cells , 2000, Infection and Immunity.
[39] D. Nikolov,et al. Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. , 2010, Molecular cell.
[40] J. Lilien,et al. Turn‐off, drop‐out: Functional state switching of cadherins , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.
[41] R. Raychowdhury,et al. Activation-Induced Expression of Carcinoembryonic Antigen-Cell Adhesion Molecule 1 Regulates Mouse T Lymphocyte Function1 , 2002, The Journal of Immunology.
[42] Urban Deutsch,et al. Angiopoietin-1 induces sprouting angiogenesis in vitro , 1998, Current Biology.
[43] G. Garcı́a-Cardeña,et al. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[44] U. Schumacher,et al. Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. , 2006, The Journal of clinical investigation.
[45] Cunji Gao,et al. The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy , 2006, Cancer biology & therapy.